← Back to Search

Device

Enhancing PCI in STEMI for Seniors

N/A
Waitlist Available
Led By David F Kong, MD
Research Sponsored by David Kong, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Accessible right or left radial artery conduit for PCI
Physician intent to perform trans-radial PCI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is studying four potential advances in care for seniors with a heart attack. The hope is that these changes will improve outcomes for these patients.

Eligible Conditions
  • Heart Attack

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You need to have a clear and accessible artery in your right or left wrist for a specific heart procedure.
Select...
The doctor plans to perform a procedure called trans-radial PCI.
Select...
You are suitable for receiving a drug-eluting stent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adjudicated 1-year Complete versus Lesion-only Primary PCI trial (CvLPRIT) MACE
Adjudicated 1-year infarct-related artery Major Adverse Cardiac and Cerebrovascular Event (MACE)
Primary Observational Endpoint - Estimate of the incidence rate of Radial Artery Occlusion (RAO)
Secondary outcome measures
Adjudicated Academic Research Consortium (ARC) definite stent thrombosis
Adjudicated Academic Research Consortium (ARC) definite/probable stent thrombosis
Adjudicated Cardiac Death
+20 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Multi-vessel Disease, Culprit Vessel OnlyExperimental Treatment4 Interventions
Subjects randomized to revascularization of infarct related artery only. Revascularization with Medtronic Resolute family of stents in infarct related artery; Possible use of Terumo Glidesheath Slender and Terumo TR Band Radial Compression Device
Group II: Multi-vessel Disease, Complete RevascularizationExperimental Treatment5 Interventions
Subjects randomized to complete revascularization. Complete revascularization of all diseased arteries with Medtronic Resolute family of stents; Use of Volcano based pressure wires Verrata, Verrata Plus and any subsequent marketed Volcano pressure wire technology to determine which arteries to stent; Possible use of Terumo Glidesheath Slender and Terumo TR Band Radial Compression Device
Group III: Single Vessel DiseaseActive Control4 Interventions
Standard of care comparator for those subjects with single vessel coronary artery disease. Revascularization with Medtronic Resolute family of stents in infarct related artery; Possible use of Terumo Glidesheath Slender and Terumo TR Band Radial Compression Device

Find a Location

Who is running the clinical trial?

Terumo Medical CorporationIndustry Sponsor
24 Previous Clinical Trials
10,004 Total Patients Enrolled
David Kong, M.D.Lead Sponsor
Medtronic VascularIndustry Sponsor
65 Previous Clinical Trials
55,634 Total Patients Enrolled

Media Library

Medtronic Resolute family of stents (Device) Clinical Trial Eligibility Overview. Trial Name: NCT02939976 — N/A
Heart Attack Research Study Groups: Multi-vessel Disease, Culprit Vessel Only, Multi-vessel Disease, Complete Revascularization, Single Vessel Disease
Heart Attack Clinical Trial 2023: Medtronic Resolute family of stents Highlights & Side Effects. Trial Name: NCT02939976 — N/A
Medtronic Resolute family of stents (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02939976 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for individuals to join this clinical research?

"As indicated on clinicaltrials.gov, this study is not currently recruiting participants; it was originally posted in August 2017 and last updated in May 2022. Although individuals are unable to join the trial at present, they can still find other medical studies actively enrolling patients - 359 of them as of now."

Answered by AI
~57 spots leftby Mar 2025